1. Home
  2. JDZG vs REVB Comparison

JDZG vs REVB Comparison

Compare JDZG & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JDZG
  • REVB
  • Stock Information
  • Founded
  • JDZG 2020
  • REVB 2020
  • Country
  • JDZG China
  • REVB United States
  • Employees
  • JDZG N/A
  • REVB N/A
  • Industry
  • JDZG Other Consumer Services
  • REVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • JDZG Real Estate
  • REVB Health Care
  • Exchange
  • JDZG Nasdaq
  • REVB Nasdaq
  • Market Cap
  • JDZG 6.2M
  • REVB 5.1M
  • IPO Year
  • JDZG 2024
  • REVB N/A
  • Fundamental
  • Price
  • JDZG $1.37
  • REVB $0.91
  • Analyst Decision
  • JDZG
  • REVB
  • Analyst Count
  • JDZG 0
  • REVB 0
  • Target Price
  • JDZG N/A
  • REVB N/A
  • AVG Volume (30 Days)
  • JDZG 22.7K
  • REVB 123.9K
  • Earning Date
  • JDZG 11-14-2025
  • REVB 11-06-2025
  • Dividend Yield
  • JDZG N/A
  • REVB N/A
  • EPS Growth
  • JDZG N/A
  • REVB N/A
  • EPS
  • JDZG 0.25
  • REVB N/A
  • Revenue
  • JDZG $2,567,741.00
  • REVB N/A
  • Revenue This Year
  • JDZG N/A
  • REVB N/A
  • Revenue Next Year
  • JDZG N/A
  • REVB N/A
  • P/E Ratio
  • JDZG $5.79
  • REVB N/A
  • Revenue Growth
  • JDZG 20.36
  • REVB N/A
  • 52 Week Low
  • JDZG $1.19
  • REVB $0.83
  • 52 Week High
  • JDZG $14.00
  • REVB $60.48
  • Technical
  • Relative Strength Index (RSI)
  • JDZG 39.90
  • REVB 37.04
  • Support Level
  • JDZG $1.19
  • REVB $0.83
  • Resistance Level
  • JDZG $1.40
  • REVB $0.88
  • Average True Range (ATR)
  • JDZG 0.10
  • REVB 0.07
  • MACD
  • JDZG -0.03
  • REVB 0.01
  • Stochastic Oscillator
  • JDZG 34.78
  • REVB 38.44

About JDZG JIADE LIMITED Common stock

Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: